The 3rd Edition of the International Cancer & Immuno-Oncology Conference (CIOC 2027) will take place from March 15–17, 2027, in Singapore, serving as a leading global forum for advancements in cancer research and immuno-oncology. Organized under the theme “Innovations in Cancer Research and Treatment for Better Patient Outcomes,” the conference brings together global experts to explore next-generation strategies in cancer prevention, diagnosis, treatment, and survivorship, with a strong emphasis on translational science and clinical application.
The scientific agenda features a broad spectrum of sessions covering oncology, immunotherapy, tumor immunology, molecular and cellular oncology, precision medicine, cancer genomics, and biomarker-driven therapies. Key discussions will also focus on emerging innovations such as CAR-T and cell-based therapies, cancer vaccines, checkpoint inhibitors, targeted drug delivery systems, liquid biopsy technologies, radiotherapy advancements, and AI-driven oncology solutions. In addition, the program highlights developments in clinical trials, drug discovery, and personalized treatment approaches aimed at improving patient outcomes.
CIOC 2027 is intended for oncologists, immunologists, cancer researchers, clinicians, surgeons, healthcare professionals, academicians, and industry stakeholders. The conference provides a dynamic platform for knowledge exchange, scientific collaboration, and networking, fostering partnerships between research and clinical communities. It aims to accelerate innovation and translate scientific discoveries into effective, patient-centered cancer care worldwide.
Reach us at:
Phone: 1 (702) 988 2320
WhatsApp: +1 (640) 666-9566
Recommended: